Jalen Hurts has deep vein thrombosis in his left leg and blood clots in both lungs, the Eagles and his agent said. The team expects a long absence that could last the rest of the season, while stating that his prognosis is very good and anticipating a full recovery. Hurts will take blood thinners and be monitored, with the Eagles planning to assess his progress over three months. Contact football is expected only after he is off the medication. The diagnosis follows his clearance to play in London and flights to and from the United States, but the available information does not show that flying caused the condition to worsen. Medical follow-up and the three-month review are the next steps.
TLDR: Hurts is being treated for clots in his leg and both lungs, and the Eagles say he may miss the rest of the season. The team plans to monitor his response to blood thinners for three months before assessing the next stage of recovery.
Philadelphia Eagles quarterback Jalen Hurts has deep vein thrombosis in his left leg and blood clots in both lungs, the team and his agent said Monday. The diagnosis could keep him out for the rest of the season. The Eagles and agent Nicole Lynn said his prognosis is very good and that they anticipate a full recovery. The condition can be life-threatening, so the expected absence is a serious measure, not a routine pause.
The stated reason for the extended absence is clear: Hurts needs treatment and close medical follow-up for a condition that can worsen if a clot travels. The team and Lynn said he has received comprehensive evaluations from physician experts over the last few days. Their update says he will continue conditioning and remain active around the team, but contact football is expected only after he is off blood thinners. That restriction keeps him from taking part in contact while his treatment continues.
Deep vein thrombosis, or DVT, means a clot has formed in a deep vein, usually in the lower body, according to the Centers for Disease Control and Prevention. A pulmonary embolism occurs when a clot breaks away and reaches the lungs, where it can block blood vessels. That can be life-threatening. In Hurts’ case, the team and his agent said clots were found in his left leg and both lungs. The diagnosis therefore includes both a clot in a deep vein and clots affecting his lungs.
The timing has raised questions because Hurts was cleared to play in London after a clot was found in his leg. A day earlier, he had been diagnosed with a superficial clot in his left calf. Reports cited in the account said doctors ordered him to stay awake overnight and that he went roughly 36 hours without sleep. He was reportedly given time to rest after leaving the hospital before playing against the Jacksonville Jaguars.
Hurts threw for 222 yards and a touchdown in that game, which the Eagles lost 19-17. After the game, he flew back to the United States with the team. Since then, the diagnosis has worsened to DVT and pulmonary emboli. The sequence has drawn backlash toward the Eagles and their medical staff, while the available information does not establish that the flights caused the progression. The account does not provide a medical explanation for how the diagnosis changed between the London game and Monday’s update.
Dr. Jon LaPook, a CBS News medical correspondent who is not treating Hurts, said flying may be relevant because passengers can become dehydrated and remain still for long periods. He said the flights to London and back within a few days could increase clot risk. The CDC likewise notes that long periods of limited movement during long-distance travel can raise the risk of venous thromboembolism. The material does not establish whether flying worsened Hurts’ condition, and the risk factors cited do not prove what happened in his case.
Travel guidance cited in the report differs. The International Air Transport Association advises that a person with stable DVT wait at least five days before flying. The British Thoracic Society advises a two-week wait for someone with DVT or PE. Those time frames are substantially longer than the interval before Hurts’ return flight, but the guidance is not evidence that the flight caused his later diagnosis. The recommendations offer context for the concern, not a finding about the cause of his condition.
The Eagles’ update gives a practical recovery timetable. The team will assess how Hurts is responding to blood thinners over three months, while his doctors follow him closely. LaPook described three months as a usual treatment period and said treatment could continue longer; he also said doctors would likely test Hurts’ blood for a possible clotting risk. The team said contact football may resume when Hurts is off the medication, and he could miss the rest of the season. The three-month assessment is a monitoring period, not a promise that he will return to play at that point.
For now, Hurts is expected to remain with the team and continue conditioning, but he will not return to contact football while taking blood thinners, according to the statement. The report gives no cost, paperwork, or public compliance requirement, and it identifies no general rule change. The immediate practical impact is the treatment and monitoring timeline, along with the restriction on contact football until he is off the medication. The next steps are medical monitoring and the three-month assessment. Those are the necessary steps for tracking his recovery, while the team’s stated outlook remains that he has a very good prognosis and is expected to recover fully.

